TGF-β triggers HBV cccDNA degradation through AID-dependent deamination-Reference-Cited by-同舟云学术

TGF-β triggers HBV cccDNA degradation through AID-dependent deamination

Published:2016-02 Issue:3 Volume:590 Page:419-427
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Qiao Ying¹,Han Xiaoxu²,Guan Gefei³,Wu Na¹,Sun Jianbo⁴,Pak Vladimir⁵,Liang Guoxin²

Affiliation:

1. The Core Laboratory for Public Health Science and Practice; The First Affiliated Hospital; China Medical University; Shenyang China

2. Key Laboratory of AIDS Immunology of the National Health and Family Planning Commission; Department of Laboratory Medicine; The First Affiliated Hospital; China Medical University; Shenyang China

3. Department of Neurosurgery; The First Affiliated Hospital; China Medical University; Shenyang China

4. Department of Microbiology and Immunology; Columbia University; New York NY USA

5. Department of Medicine; Microbiology and Immunology; University of California; San Francisco CA USA

Funder

Scientific Research Foundation for the Returned Overseas Chinese Scholars

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/1873-3468.12058/fullpdf

Reference34 articles.

1. Hepatitis B virus-cell interactions and pathogenesis;Nguyen;J Cell Physiol,2008

2. Hepatitis B viruses: reverse transcription a different way;Nassal;Virus Res,2008

3. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones;Pollicino;Gastroenterology,2006

4. Natural and iatrogenic variation in hepatitis B virus;Ngui;Rev Med Virol,1999

5. Control of cccDNA function in hepatitis B virus infection;Levrero;J Hepatol,2009

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation Study between STAT4 Gene Polymorphism and Cytokine Secretion Levels in Patients with Chronic Hepatitis B;Advances in Clinical Medicine;2024

2. Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA;Viruses;2023-11-25

3. Chronic inflammation and the hallmarks of aging;Molecular Metabolism;2023-08

4. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity;Frontiers in Cellular and Infection Microbiology;2023-06-22

5. Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus;Molecular Therapy - Nucleic Acids;2023-06